Antidepressants for prevention of severe COVID-19, Long COVID and outlook for other viral diseases

Front Med (Lausanne). 2024 Feb 20:11:1305184. doi: 10.3389/fmed.2024.1305184. eCollection 2024.

Udo Bonnet^{1

2}, Georg Juckel³, Jens Kuhn^{4

5}

¹ Department of Mental Health, Evangelisches Krankenhaus Castrop-Rauxel, Academic Teaching Hospital of the University of Duisburg/Essen, Castrop-Rauxel, Germany.
² Department of Psychiatry and Psychotherapy, Faculty of Medicine, Landschaftsverband Rheinland-Hospital Essen, University of Duisburg-Essen, Essen, Germany.
³ Department of Psychiatry, Psychotherapy and Preventive Medicine, LWL University Hospital, Ruhr University Bochum, Bochum, Germany.
⁴ Department of Psychiatry and Psychotherapy, University Hospital Cologne, Cologne, Germany.
⁵ Alexianer Hospital Cologne, Cologne, Germany.

No abstract available

Keywords: COVID-19; Long COVID; PACS; Post COVID; antidepressants; prevention; resilience.

Grants and funding

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.